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Abstract.  We have investigated the role of trkA,  the 
tyrosine kinase NGF receptor,  in mediating the sur- 
vival response of embryonic neurons to NGF.  Em- 
bryonic trigeminal  mesencephalic (TMN) neurons, 
which normally survive in the presence of brain- 
derived neurotrophic factor (BDNF) but not NGF, be- 
come NGF-responsive when microinjected with an ex- 
pression vector containing trkA eDNA. In contrast, 
microinjection of ciliary neurotrophic  factor 
(CNTF)-dependent embryonic ciliary neurons with the 
same construct does not result in the acquisition of 
NGF responsiveness by these neurons despite de novo 
expression of trkA mRNA and protein.  The failure of 
trkA to result in an NGF-promoted survival response 
in ciliary neurons is not due to absence of the low- 
affinity NGF receptor, 1575, in these neurons.  Quantita- 
tive RT/PCR and immunocytoehemistry showed that 
TMN and ciliary neurons both express p75 mRNA and 
protein.  These findings not only provide the first direct 
experimental demonstration of trkA mediating a physi- 
ological response in an appropriate cell type, namely 
NGF-promoted survival of embryonic neurons, but in- 
dicate that not all neurons are able to respond to a 
trkA-mediated signal transduction event. 
W 
ORK on NGF has substantiated the proposal that the 
survival  of developing  neurons  depends  on  the 
supply of neurotrophic  factors from their  target 
fields and that the limited production of these factors results 
in the death of superfluous  neurons (Davies,  1988b; Barde, 
1989).  NGF  is  synthesized  in  the  target  fields  of NGF- 
dependent  neurons  during  development  (Davies  et  al., 
1987a; Korsching and Thoenen, 1988) in relation to the final 
innervation  density  (Harper  and  Davies,  1990)  and  ex- 
perimental manipulation  of the availability of NGF shortly 
after  these neurons  innervate  their  targets  influences  the 
number of neurons that survive (Levi-Montalcini  and An- 
geletti,  1968; Johnson et al.,  1982). 
NGF is  a  member of an homologous family  of neuro- 
trophic  factors that  comprises brain-derived neurotrophic 
factor (BDNF)  l (Barde et al., 1982; Leibrock et al.,  1989), 
neurotrophic factor-3 (Hohn et al.,  1990;  Maisonpierre et 
al., 1990; Ernfors et al., 1990; Rosenthal et al., 1990; Jones 
and Reichardt,  1990), Xenopus NT-4 (Hallbook et al., 1991), 
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and mammalian  NT-4/5 (Berkemeier et al.,  1991; Ip et al., 
1992a).  The available evidence suggests that each of these 
factors promotes the  survival  of a  distinctive  set of em- 
bryonic neurons.  For example,  NGF promotes the survival 
of sympathetic neurons (Chun and Patterson,  1977; Greene, 
1977), certain populations  of sensory neurons (Davies and 
Lindsay,  1985),  and  basal  forebrain  cholinergic  neurons 
(Hatanaka et al.,  1988), whereas BDNF promotes the sur- 
vival  of NGF-insensitive  sensory neurons  (Davies  et al., 
1986b; Lindsay et al., 1985), retinal ganglion cells (Johnson 
et al., 1986), and the doparninergic neurons of the substantia 
nigra (Hyman et al.,  1991). In addition  to members of the 
NGF family of small basic homodimeric proteins,  several 
unrelated  proteins are capable of promoting the survival of 
various neurons at particular stages of their development.  Of 
these proteins,  ciliary neurotrophic  factor (CNTF), a small 
acidic protein,  is the most extensively studied (Barbin et al., 
1984; Lin et al., 1989; Stockli et al., 1989). This factor pro- 
motes the survival of a wide variety of embryonic neurons, 
including many of those supported by members of the NGF 
family of neurotrophic  factors (Barbin et al., 1984; Ip et al., 
1991;  Buj-Bello,  A.,  and  A.  M.  Davies,  unpublished 
findings). 
Two kinds of transmembrane glycoproteins  are receptors 
for members of the NGF family of neurotrophic  factors: p75 
(Chao et al.,  1986; Johnson et al.,  1986;  Radeke et al., 
1987) and members of the trk family  of tyrosine kinases 
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et al.,  1991; Berkemeier et al.,  1991; Cordon et al.,  1991; 
Glass et al., 1991; Hempstead et al., 1991; Lamballe et al., 
1991; Meakin et al.,  1992;  Soppet et al.,  1991; Squinto et 
al., 1991). Whereas p75 binds NGF, BDNF, and NT-3 with 
equal low-affinity (Sutter et al., 1979;  Rodriguez-Ttbar and 
Barde, 1990; Rodriguez-Ttbar et al., 1992),  trk tyrosine ki- 
nases exhibit a greater degree of specificity: trkA binds NGF, 
NT-3, and NT-4/5;  trkB binds BDNF, NT-3, and NT-4/5 and 
trkC binds NT-3. 
The  demonstration  that  neurotrophic  factors  promote 
rapid transphosphorylation of trk tyrosine kinases (Kaplan et 
al., 1991a, b; Klein et al., 1991a, b; Soppet et al., 1991) and 
elicit a response from oocytes and cell lines transfected with 
trk cDNAs (Cordon et al., 1991; Glass et al., 1991; Lamballe 
et al., 1991; Loeb et al., 1991; Nebreda et al., 1991; Squinto 
et al., 1991) suggests that these tyrosine kinase receptors are 
directly involved in mediating the action of neurotrophic fac- 
tor receptors.  Although p75  is probably not a  functional 
receptor  on  its  own  (Hempstead  et  al.,  1989),  several 
findings suggest that p75 is required for certain responses to 
neurotrophic factors. Membrane fusion and cell transfection 
experiments suggest that both p75 and trk have to be present 
for the formation of specific, functional, high-affinity NGF 
receptors (Hempstead et al.,  1989, 1991; Matsushima and 
Bogenmann, 1990; Pleasure et al., 1990).  PC12 cells trans- 
fected with chimeric receptors consisting of the extracellular 
domain of the EGF receptor and the transmembrane and in- 
tracellular domains of p75  extend neurites in response to 
EGF (Yan et al., 1991). Antisense p75 oligonucleotides inter- 
fere with kidney morphogenesis (Sariola et al., 1991) and re- 
tard an early maturational change in developing sensory neu- 
rons (Wright et al., 1992).  A null mutation of the p75 gene 
in  mice  associated  with  a  marked  sensory  deficit  in 
homozygotes that is due to loss of cutaneous sensory nerve 
fibres (Lee et al., 1992). In contrast to these studies, preven- 
tion of NGF binding to p75  by either anti-p75  antiserum 
(Weskamp and Reichardt, 1991) or mutation of  the NGF pro- 
tein (Ibanez et al., 1992) does not apparently interfere with 
the action of NGE Also, transfection of trkA, trkB, or trkC 
into 3T3 fibroblasts (a cell type lacking p75) results in the 
proliferation of these cells in response to neurotrophic fac- 
tors (Cordon et al.,  1991; Glass et al.,  1991; Klein et al., 
1992; Lamballe et al., 1991) suggesting that p75 is not essen- 
tial for signal transduction. 
To date, all cell transfection experiments using the trk fam- 
ily of neurotrophic factor receptors have been carried out in 
oocytes, PC12 pheochromocytoma cells and fibroblast cell 
lines. Although these studies have provided valuable data on 
the function and potential specificity of trk tyrosine kinase 
receptors,  the  mechanism  of  neurotrophic  factor  signal 
transduction leading to survival in neurons may differ from 
signal transduction associated with mitogenesis or differenti- 
ation in physiologically irrelevant cell types. For these rea- 
sons we have studied the role of trk.d in mediating an appro- 
priate cellular response to NGF in an appropriate cell type 
at the relevant stage of  development. We have used two NGF- 
insensitive populations of cranial neurons at the stage when 
they are  dependent on neurotrophic  factors for  survival. 
During the phase of naturally occurring neuronal death, the 
survival of the neural crest-derived proprioceptive neurons 
of the trigeminal mesencephalic nucleus (TMN) is promoted 
by BDNF (Davies et al., 1986a, b) and a muscle-derived fac- 
tor (Davies, 1986) that may be NT-3 (Hohn et al., 1990).  At 
the same stage of development, the survival of the neural 
crest-derived parasympathetic neurons of the ciliary gan- 
glion is promoted by CNTF (Barbin et al., 1984). NGF does 
not, however, promote the survival of either TMN (Davies 
et al.,  1987b) or ciliary (Helfand et al.,  1976;  Rohrer and 
Sommer, 1982) neurons in dissociated culture at this stage. 
We have shown that microinjection of a trkA expression 
vector  into  two  different populations  of NGF-insensitive 
neurons leads to an NGF-promoted survival response from 
only one of these despite the expression of trkA and p75 
mRNA and protein in both populations. Our results directly 
demonstrate that trkA mediates the survival response of em- 
bryonic neurons to NGF, but show that not all neurotrophic 
factor-dependent neurons are able to survive in response to 
NGF  even if they express  both components of the NGF 
receptor. 
Materials and Methods 
Materials 
Purified recombinant human NGF, human BDNF, and rat CNTF were gifts 
of Gene Burton, John Winslow, and Dave Shelton (Genentech Inc., San 
Francisco,  CA). These factors  were used at a final concentration  of 2 ng/mi, 
which is the maximally effective concentration  of BDNF and CNTF for sup- 
porting the survival of El0 TMN and ciliary neurons, respectively, and is 
the maximally effective concentration of NGF for supporting the survival 
of the NGF-dependent dorsomedial trigeminal ganglion (DMTG)  neurons 
(data not shown). A full-length rat trkA cDNA was a gift of Susan Meakin, 
Philip Barker,  and  Eric  Shooter  (Stanford  University,  Stanford,  CA). 
Anti-chicken p75 antiserum was a gilt of C-isela Weskamp (University of 
California, San Francisco,  CA). An anti-trkA antiserum that recognizes the 
COOH-terminal receptor kinase domain (Kozma et al., 1988) was a gift of 
Aviva Tolkovsky (Oxford University, Oxford).  Anti-chicken 70-kD neuro- 
filament antiserum was a gift of Diana Moss (Liverpool  University, Liver- 
pool,  UK).  PCR primers were  synthesized  on an Applied Biosystems 
PCR-Mate DNA synthesizer (Applied Biosystems, Inc., Foster City, CA). 
Poly-ornithine and EHS laminin were purchased from Sigma Chemical Co. 
(St. Louis, MO). All tissue culture dishes and reagents were obtained from 
GIBCO BRL (Galthershurg,  MD). 
Cell Culture 
Fertile white Leghorn chicken eggs were incubated at 38"C in a forced-draft 
incubator.  After 10 d of incubation (El{)), ciliary ganglia and the midline 
part of the TMN were dissected from the embryos using eleetrolytieaily 
sharpened tungsten needles (Davies,  1988a).  After incubation with 0.1% 
trypsin in calcium and magnesium-free  HBBS for 9 rain at 37"C, the dis- 
sected tissue was  washed twice in Ham's  FI2 medium plus  10%  heat- 
inactivated  horse serum (HII-IS) and was dissociated  by gentle trituration 
using a siliconised,  fire-polished  Pasteur pipette.  Nonneuronal cells were 
removed by differential sedimentation  through a precooled column of Ham's 
F14 medium containing 10% HIHS (Davies,  1988a). The column fractions 
containing the neurons were centrifuged at 2,000 g for 5 rain and the neu- 
rons were plated in 60-ram-diameter tissue culture dishes that had been 
coated with polyornithine (0.5 t~g/ml in 0.15 M borate buffer, pH 8.7, over- 
night) and laminin (20 pg/ml in F14 medium, 411). The cells were cultured 
in 5 ml of Ham's FI4 medium supplemented with 10% H1HS, 5% heat- 
inactivated  FCS (HIFCS),  penicillin (60 mg/l), streptomycin  (100 mg/l), 
and 24 mM NaHCO3,  with or without neurotrophic factors,  at 37°C in a 
humidified 4% CO2 incubator. 
Cell Microinjection 
Before injection, the neurons were washed (3 x  3 ml washes over 10 min) 
with warm F12 medium supplemented with 10% I-HHS plus 5 % HIFCS and 
were placed in this medium without neurotrophic factors on the stage of a 
Nikon Diaphot inverted microscope (Nikon Inc., Melville, NY).  The mi- 
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Greenvale, NY) that was attached to the microscope were enclosed within 
a humidified incubator chamber that was maintained at 37*C. Cell injection 
pipettes (GD-1; Narishige) were pulled on a Camlxlen Instruments moving 
coil puller. All neurons within an area that was marked on the inside of the 
culture  dish  were  pressure-injected with  either  the  sense or  antisense 
pCMX-trkA  construct (rat trkA eDNA subcloned into the XbaI site of the 
pCMX expression vector in both orientations with respect to the constitu- 
tively active CMV promoter) at a concentration of 100/~g/mi  in PBS. Each 
neuron was injected until slight cell swelling was observed, which usually 
took place within a few seconds. More than 95 % of the neurons that re- 
ceived intra-nuclear injection were still surviving 1 h after injection. Neu- 
rons within a  separate marked area of the same culture dishes served as 
uninjected control cells. After injection, the neurons were washed (3  x  3 
ml washes over 10 rain) with warm F14 culture medium and cell counts were 
carried out to determine the initial sizes of  the injected and uninjected popu- 
lations. The numbers of neurons surviving 24 and 48 h after injection were 
counted and are expressed as a percentage of the postinjection number. 
Immunocytochemistry 
Cells were stained for trkA protein between 24 and 48 h after injection as 
follows. The cultures were washed twice with warm serum-free F14 medium 
and were fixed with 4 % paraformaldehyde for 30 min at room temperature. 
After washing twice with PBS, the cells were permeabilized with 0.3 % Tri- 
ton X-100 in PBS for 20 rain and were incubated with 10% HIHS in PBS 
for a further 30 min (all at room temperature). The dish area surrounding 
the neurons to be stained was dried and 150-200/~I of anti-trk antiserum 
(1:400 dilution in PBS plus 1% HIHS) was applied for 60 min at room tem- 
perature. After washing with PBS (3 x  5 ml over 10 rain), the neurons were 
incubated with Texas red-conjugated goat anti-rabbit IgG antibody (1:750 
dilution in PBS plus 1% HIHS) for 60 rain at room temperature. This sec- 
ondary antiserum had been extensively absorbed to remove cross-species 
reacting antibodies. Finally, the neurons were washed with PBS and were 
mounted in  Citifluor beneath glass coverslips. Immunofluorescent cells 
were viewed with a Nikon diaphot microscope equipped with epifluores- 
cence and were photographed using Kodak T-Max 400 film (Eastman Ko- 
dak Co., Rochester, NY). No immunofluorescence  was observed in cultures 
that were stained with second antisera alone. 
Cell-surface expression of 195 was detected using a rabbit anti-chicken 
195 antiserum (gift of Gisela Weskamp). Paraformaldehyde-fixed cultures 
were incubated for 1 h at room temperature with 5/zg/ml of this antiserum 
in PBS plus 1% normal rabbit serum. After washing, the cultures were in- 
cubated  for  60  min  with  a  1:100  dilution  of  FITC-conjugated  goat 
anti-rabbit IgG secondary antibody. After washing with PBS, the cultures 
were photographed as described above. No immunofluorescence was ob- 
served in cultures that were stained with second antisera alone. 
Measurement of  p75 mRNA in TMN and 
Ciliary Neurons 
A quantitative reverse transcription/PCR (RT/PCR) technique was used to 
determine if TMN and ciliary neurons express 195 mRNA. This technique 
is based on the co-reverse transcription and co-amplification of 195 mRNA 
and a slightly larger 195 RNA standard. Because the target mRNA and con- 
trol RNA are present in the same reverse transcription and PCR amplifica- 
tion reactions and use the same primers, the effect of  the numerous variables 
that  influence  the  efficiency of amplification  is  nullified;  the  relative 
amounts of the amplified products reflect the relative concentrations of the 
195 mRNA and 195 control RNA in the original reaction mixture. 
Differential sedimentation (Davies,  1986)  was used to purify neurons 
(>98 % enrichment) from dissociated cell suspensions of the TMN and 
ciliary ganglia. Total  RNA (Chomczynski and Sacchi,  1987)  was reverse 
transcribed using GIBCO BRL Superscript enzyme in the supplied buffer 
plus 0.5  mM dNTPs and  10 ttM random hexanucleotides for 45 min at 
370C.  10-td aliquots were added to 50-/~1 PCR reactions containing NBL 
Taq DNA polymerase in the supplied buffer adjusted to 1.85 mM MgCI2 
plus 0.1 mM dNTPs and 6 #1 of 32p-labeled oligonueleotide primers. The 
primers were: (5') 5'-CCTGTGTACTGCTCTATCCTGG-3'and (3') 5"TTG- 
TTCTGCTTGCAGCTGTTCC-3'.  These  hybridize  100  bp  apart  in  the 
chicken 195 sequence (Large et al., 1989).  These primers were synthesized 
on an Applied Biosystems DNA synthesizer  and were labeled at their 5' ends 
in a 40-tzl reaction containing 4 t~l of 10 x  T4 polynucleotide kinase buffer 
(0.5  M TRIS, pH 7.6, 100 mM MgC12,  1 mM spermidine, 50 mM DTT, 
1  mM  EDTA,  pH  8),  2  /~g  of each  primer,  30  /~l  v32p-ATP  (3,000 
Ci/mmol,  10 mCi/ml) and 4.5/zl of T4 polynucleotide kinase (10 U/td). 
The reaction was mixed thoroughly and incubated at 37"C for45 min, after 
which a further 5 td of polynucleotide kinase were added, followed by a 
further 45-min incubation at 37"C. The labeled primers were purified from 
the reaction mixture using the Stratech Mermaid kit.  135 #1 of high-salt 
binding solution (supplied with the ki0 were added to the reaction followed 
by 50/~1 of Mermaid glassfng. This was mixed thoroughly and left for 15 
min at room temperature to permit the primers to bind to the glassfog. The 
mixture  was  microfuged  briefly  to  sediment the  glassfng plus  bound 
primers. After washing the glassfog twice with the solution provided, the 
primers were ehited into 250 td of water by incubation at 60"C for 10 min. 
6/~1 of this solution were used per PCR reaction. 195 eDNA was amplified 
by eight cycles of 94°C for 60 s, 54°C for 90 s, and 72"C fur 45 s followed 
by 15 cycles of 91°C for 60 s, 52°C for 120 s, and 72°C for 120 s. There 
was a final 72"C incubation for 10 min. 
The  above conditions are  optimal  for reverse transcription and  am- 
plification of 25-50 fg of p75 gene run-off transcripts such that the rate of 
reaction does not plateau. PCR products were analyzed after electrophore- 
sis of reaction aliquots on 7% acrylamide/TBE gels and autoradiography. 
The  level  of 195  mRNA  in  the extracted RNA  was  quantified by  co- 
amplifying with standard run-off transcripts from the 1075 eDNA (gift of 
Tom Large) which have an additional 4 bp insert between the primer anneal- 
ing sites. 50 fg standard transcripts were added to RNA from approximately 
50 El0 TMN and 50 ciliary neurons. Densitometry was used to determine 
the level of 195  mRNA by comparing the relative intensities of the 195 
mRNA and 195 RNA standard bands. 
To compare the relative level of  p75 mRNA in TMN and ciliary neurons, 
the level of the mRNA encoding the ubiquitous, constitutively expressed 
L27 ribosomal protein was also measured in RNA samples from TMN and 
ciliary neurons by a quantitative PCR amplification technique. The level of 
1375 mRNA in samples could then be expressed relative to the level of L27 
mRNA in these samples. The experimental error of  this method was consis- 
tently smaller than that of relating the level of 195 mRNA to the number 
of neurons in cell pellets determined by haemocytometry. To determine the 
level of L27 mRNA,  10-td aliquots of reverse transcribed neuronal total 
RNA were added to 50-td PCR reactions containing NBL Taq DNA poly- 
merase in the supplied buffer plus 5/zl of the following labeled.primers: 
(5') 5'-GGCTGTCATCG'IGAACAT-3'  and (33 5'-CTTCGCTATCTTCTT- 
CTTGCC-3'.  These hybridize 127 bp apart in the chicken L27 sequence 
(Lebeau et al., 1991) and were labeled as described for the 195 primers. L27 
eDNA was amplified by eight cycles of 94°C for 60 s, 60°C for 105 s, 
and 72°C for 45 s followed by 17 cycles of 91°C for 60 s, 58°C for 180 s, 
and 72°C for 180 s. There was a final 72"C incubation fur 10 rain. 
The  above conditions are  optimal  for reverse transcription and  am- 
plification of  500 fg of  L27 gane run-offtranscripts such that the rate of  reac- 
tion does not plateau. PCR products were analyzed after electrophoresis of 
reaction aliquots on 7 % acrylamide/TBE gels and autoradingraphy. The 
level of L27 mRNA in the extracted RNA was quantified by co-amplifyiug 
with standard run-off transcripts from the L27 cDNA which have an addi- 
tional 4-bp insert between the primer annealing sites. 360 hp of L27 eDNA 
was obtained by reverse transcription of  total RNA from Ell chicken dorsal 
root ganglia and subsequent PCR amplification using primers based on the 
published L27 cDNA sequence (Lebeau et al., 1991). 500-fg standard tran- 
scripts were added to varying amounts of total RNA from El0 TMN and 
ciliary neurons. Samples in which mRNA and standard bands were of simi- 
lar intensity were used to calculate L27 mRNA in each RNA sample. Au- 
toradiographs were scanned with a Personal Densitometer (Molecular Dy- 
namics Inc., Kent, England). The levels of  195 mRNA and L27 mRNA were 
determined by calculating the ratios between the amplification products of 
these mRNAs and their corresponding RNA standard amplification prod- 
ucts and multiplying the known amounts of the initial RNA standards by 
these ratios. The results are expressed as the quotient of the amount of 195 
mRNA and the amount of L27 mRNA in RNA extracted from TMN or 
ciliary neurons. 
Measurement of trkA mRNA in Injected TMN and 
Ciliary Neurons 
A RT/PCR technique was also used to determine if TMN and ciliary neu- 
rons express trkA mRNA after injection with the pCMX-trkA construct. To- 
tal RNA extracted from injected neurons was reverse transcribed as de- 
scribed above. The level of trkA mRNA was quantified by co-amplifying 
with a run-off transcript from a rat trkA eDNA that had an additional 3-bp 
insert between the primer annealing sites. 50 fg of standard transcripts were 
added to RNA from approximately equal numbers of  injected El0 TMN and 
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reaction products on 7% acrylamide/TBE gels and autoradiography. The 
primers for trkA were:  forward 5'-CGIV_ATGC_~TGCTTTTATGG-3' and 
reverse 5'-ACTGGCGAGAAGGAGACAG-3'. The cycling conditions were: 
60 s at 94"C, 60 s at 55"C, 60 s at 72"C for 22 cycles. The relative levels 
of trkA mRNA in injected ciliary and TMN neurons were assessed by com- 
paring ratios of standard RNA to trkA mRNA amplification products in 
RNA extracted from these neurons. 
Results 
To investigate the role of trkA in mediating the survival re- 
sponse of embryonic neurons to NGF, we microinjected the 
NGF-insensitive TMN and ciliary ganglion neurons with the 
pCMX vector containing trkA eDNA to see if trkA expres- 
sion would permit these neurons to respond appropriately to 
NGF. Experiments were carried out at the tenth day of em- 
bryonic development (El0) when the survival of these neu- 
rons depends on BDNF and CNTF, respectively. To devise 
a suitable injection protocol for the experiments, we studied 
the rate at which El0 TMN and ciliary neurons die in culture 
when deprived of neurotrophic factors. When cultured in the 
absence of nonneuronal ceils in medium without added neu- 
rotrophic factors, >80% of these neurons died within 12 h. 
Similarly, if TMN and ciliary neurons were grown for 12 h 
with BDNF and CNTF, respectively, and deprived of these 
factors by extensive washing they also died rapidly. In these 
circumstances,  10% or less of the neurons survived 48 h af- 
ter neurotrophic  factor deprivation (data not shown).  The 
finding that neurons could be initially maintained in culture 
with  neurotrophic  factors  and  died  rapidly  after  their 
removal was  particularly  advantageous  for microinjection 
experiments. This facilitated the preparation of large num- 
bers of healthy neurons that were well attached to the culture 
substratum for microinjection. It also provided a very sensi- 
tive assay for ability of trkA to rescue neurons growing with 
NGF because virtually all of the neurons in control cultures 
died 48 h  after neurotrophic factor deprivation. 
TMN Neurons Survive in Response to NGF After 
Injection with the pCMX/trkA Expression Vector 
When TMN neurons were grown for 12 h in the presence of 
BDNF and deprived of this factor by extensive washing, only 
10%  of the  neurons  survived for the  next 48  h  in  NGF- 
supplemented cultures compared with 80%  in cultures re- 
supplemented with  BDNF  (Fig.  1).  The small number of 
neurons surviving with 2  ng/ml NGF was not significantly 
different  from the  number  surviving in  NGF-free culture 
medium (data not shown).  Furthermore, concentrations of 
NGF up to 5  t~g/ml did not promote the survival of TMN 
neurons above this low background level (data not shown). 
When TMN neurons were injected with pCMX/trkA expres- 
sion vector immediately after BDNF deprivation and grown 
with 2 ng/ml NGE almost 50 % of the neurons survived for 
the next 48 h. This response of injected neurons to NGF was 
not due to some non-specific effect of the injection because 
neurons that were injected with the pCMX vector that had 
the trkA cDNA subcloned in the antisense orientation did not 
show an enhanced survival response when grown with NGF 
(Fig.  1).  Approximately 70%  of the neurons injected with 
the trk expression vector survived when grown in medium 
re-supplemented  with  BDNF  (Fig.  1).  This  showed  that 
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Figure 1.  El0 TMN neurons survive with NGF after injection of 
trkA vector. Bar chart of the percent survival of El0 TMN neurons. 
After 12 h of incubation with saturating levels of BDNF (2 ng/ml), 
the neurons  were deprived of BDNF by extensive washing. The 
neurons were then treated in one of several ways: resupplemented 
with BDNF (column set  1),  grown without  neurotrophic  factor 
(column set 2), microinjected  with the pCMX expression vector 
containing trkA eDNA in the sense orientation  and grown with 2 
ng/ml NGF (column set 3), microinjected with the pCMX expres- 
sion vector containing trkA eDNA in the antisense orientation and 
grown with 2 ng/ml NGF (column set 4), or microinjected with the 
pCMX expression vector containing trkA eDNA in the sense orien- 
tation and grown with 2 ng/ml BDNF (column set 5). Neuronal 
survival  was assessed  24  (B)  and  48  (n)  h  after initial  BDNF 
deprivation and is expressed as a percentage of the number of neu- 
rons in the corresponding cultures at the time of  BDNF deprivation. 
The mean (bar height) and standard error (error bars) of the results 
from five experiments are shown (,'~  1,300 injected neurons). 
detrimental  to  TMN  neurons.  Despite  this,  however,  we 
were never able to achieve >50%  survival of injected TMN 
neurons cultured with NGF (five experiments;  "~1,300  in- 
jected  neurons).  Exposure  of pCMX/trkA-injected  TMN 
neurons to super-saturating levels of NGF (2 #g/ml) failed 
to  increase  the  number  of  surviving  neurons  (data  not 
shown),  suggesting  that  sub-optimal  receptor  occupancy 
could not account for the lower survival response of these 
cells to NGF. 
To demonstrate that trkA protein is synthesized in TMN 
neurons from the injected trkA eDNA template, we used an 
antiserum that recognizes the kinase domain of this protein 
(Kozma et al.,  1988).  This antibody was raised against the 
carboxy-terminal kinase  domain  of human  trkA  and  im- 
munoprecipitates from membrane extracts of sympathetic 
neurons a  140-kD phosphotyrosine glycoprotein that binds 
iodinated  NGF  (A.  Tolkovsky, personal  communication). 
The  majority  of pCMX/trkA-injected  TMN  neurons  ex- 
hibited intense staining of the cell body and distinct, though 
faint, staining of neurites 12 or 24 h after injection (Fig. 2). 
Uninjected neurons and neurons injected with vector alone 
or vector with trkA eDNA subcloned in the antisense orien- 
tation exhibited only very faint immunoreactivity restricted 
to the cell body. Although there was some variation in stain- 
ing intensity of the cell body among injected neurons, the 
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jected with the pCMX/trkA ex- 
pression vector synthesize trkA 
protein.  Phase contrast  (a and 
c)  and  corresponding  fluores- 
cent  images  (b and  d)  of El0 
TMN  neurons.  The  neurons 
were  either  injected  with  the 
pCMX/trkA expression  vector 
and grown with 2  ng/ml NGF 
(a  and  b),  or  remained  unin- 
jected and grown with 2 ng/ml 
BDNF (c and d) for 24 h. The 
cells were then fixed, permeabi- 
lized and stained  for trkA pro- 
tein using an antiserum that rec- 
ognizes  the  kinase  domain  of 
the protein.  The injected TMN 
neurons exhibited intense stain- 
ing of the cell body (b) and dis- 
tinct,  though  faint,  staining  of 
neurites  (b; white arrowhead). 
Some of the uninjected neurons 
exhibited a very faint immuno- 
reactivity  restricted  to the cell 
body (d). The staining imensity 
of  all  injected  neurons  was 
much greater than the very low 
level  of  staining  observed  in 
uninjected neurons. Neither in- 
jected  nor  uninjected  neurons 
were stained by secondary anti- 
body alone. Bar,  100 #m. 
staining intensity of all injected neurons was clearly greater 
than the very low level of staining  observed in uninjected 
neurons.  Additionally,  uninjected  neurons  never displayed 
neurite staining.  At the resolution of our microscopy, how- 
ever, we were not able to ascertain whether trkA staining was 
localized predominantly to the plasma membrane, as would 
be required  for NGF binding.  Neither injected  nor unin- 
jected neurons were stained by secondary antibody alone. It 
is likely that the very low level of immunoreactivity in unin- 
jected neurons may have been due to cross-reactivity of the 
antiserum with the highly conserved kinase domains of other 
irk tyrosine kinase family members. 
Because only pCMX/trkA-injected  neurons exhibited trkA 
immunoreactivity in neurites, we were able to compare the 
proportion  of  pCMX/trkA-injected  neurons  that  showed 
positive neurite staining when grown in the presence of ei- 
ther NGF or BDNE Table I shows that the majority of TMN 
neurons  showed neurite staining when grown under either 
condition. 
Ciliary Neurons Do Not Survive in Response 
to NGF After Injection with the pCMX/trkA 
Expression Vector 
When ciliary neurons were grown for 12 h with CNTF and 
deprived of this factor by extensive washing,  <10%  of the 
neurons  survived for the next 48 h  in NGF-supplemented 
cultures  compared  with  60%  surviving  in  cultures  re- 
supplemented with CNTF (Fig. 3). As in TMN cultures, the 
very small number of ciliary neurons surviving with 2 ng/ml 
NGF was not significantly different from the number surviv- 
ing in NGF-free culture medium. In contrast to TMN neu- 
rons, NGF failed to rescue ciliary neurons injected with the 
trkA  expression  vector immediately after  CNTF  depriva- 
tion.  There was negligible difference in the number of sur- 
viving injected and uninjected ciliary neurons grown with 2 
ng/ml NGF for 48 h. The lack of an NGF survival response 
from pCMX/trkA-injected ciliary neurons was not due to the 
trauma of injection or to some nonspecific detrimental effect 
Table I. Similar Percentages of TMN and Ciliary Neurons 
Express trkA Immunostaining in Neurites After Injection 
with the pCMX/trkA  Expression  Vector 
Percent  Percent with 
Factor  survival  stained neuritcs 
TMN neurons  BDNF  79  +  5  72  +  11 
NGF  63  +  13  70  +  4 
Ciliary neurons  CNTF  81  +  7  61  4- 6 
NGF  17 4- 2  43  4-  13 
TMN and ciliary neurons were grown for 12 h with BDNF and CNTF, respec- 
tively, before being deprived and injected with the trkA/pCMX expression vec- 
tor.  The  neurons  were then grown for a further  24  h with either  the  same 
neurotrophic factor or NGF. The surviving neurons were fixed and processed 
for immunocytochemistry using the anti-trkA antiserum. Neurons scored posi- 
tive for trkA immunostaining if they displayed neurite staining. The number of 
neurite-stained neurons is expressed as a percentage of the surviving neuron 
population. The neurons surviving are expressed as a percentage of the starting 
neuronal population at the time of injection.  Data are compiled from two in- 
dependent experiments each of which was set up in duplicate; the mean + stan- 
dard deviation are shown. 
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Figure 3. Ciliary neurons do not survive with NGF after injection 
with the pCMX/trkA expression vector. Bar chart of the percent 
survival of El0 ciliary neurons. After 12 h incubation with saturat- 
ing levels of CNTF (3 ng/ml), the neurons were deprived of CNTF 
by extensive washing.  The neurons were then treated in one of sev- 
eral ways: resupplemented with CNTF (column set 1 ), grown with- 
out  neurotrophic  factor  (column  set  2),  microinjected  with  the 
pCMX expression vector containing trkA in the sense orientation 
and grown with 2 ng/ml NGF (column set 3), microinjected with 
the pCMX expression vector containing trkA in the antisense orien- 
tation and grown with 2 ng/ml NGF (column set 4), or microin- 
jected  with the pCMX expression vector containing  trkA in the 
sense orientation and grown with 3 ng/ml CNTF (column set 5). 
Neuronal survival was assessed 24 (=) and 48  (r~) h  after initial 
CNTF deprivation and is expressed as a percentage of the number 
of neurons in the corresponding cultures at the time of CNTF depri- 
vation.  The mean (bar height) and standard error (error bars) of  the 
results are from two experiments (~800  injected neurons). 
of  the  pCMX/trkA  construct  in  ciliary  neurons  because 
pCMX/trkA injection did not affect the survival response of 
ciliary neurons  to CNTF;  virtually the same proportion of 
injected and uninjected ciliary neurons survived for 48 h  in 
medium containing  CNTF  (Fig.  3). 
pCMX/trkA-injected TMN and Ciliary Neurons 
Express Rat trkA mRNA and Protein 
To determine  if trkA-expressing  TMN  and  ciliary  neurons 
differ in their ability to express trkA mRNA after injection 
with the pCMX/trkA vector, we used RT/PCR amplification 
of trkA mRNA from TMN and ciliary neurons that had been 
injected  with the pCMX/trkA expression vector and main- 
tained in NGF for 24 h. PCR primers were designed accord- 
ing to the published rat trkA cDNA sequence (Meakin et al., 
1992). RT/PCR was performed on aliquots of RNA extracted 
from equal  numbers  of injected  ciliary  and  TMN  neurons 
and the efficiency of the  RT/PCR reactions  was monitored 
by the inclusion of a known amount of a slightly smaller trkA 
RNA transcript.  Fig. 4  (lanes 3 and 5) shows that there was 
no obvious difference in the ratio between the amplification 
products of trkA mRNA and trkA RNA standard,  indicating 
that trkA mRNA was transcribed with equal efficiency from 
Figure 4. TMN and Ciliary neurons injected with the pCMX/trkA 
expression vector express equivalent amounts of trkA mRNA. Au- 
toradiograph of PCR amplification products electrophosed on a 7 % 
nondenaturing polyacrylamide gel. Total RNA from equal numbers 
of injected and uninjected El0 TMN and ciliary neurons grown for 
24 h with NGF was reverse transcribed and a 79-bp fragment of 
trkA cDNA was amplified by PCR using end-labeled trkA-specific 
primers (arrow  b). In each case 50 fg of a trkA cRNA control tem- 
plate with a 3-bp insert between primer annealing sites was added 
to reverse transcription reactions prior to amplification to generate 
an 82-bp fragment (arrow a). Lane 1,  no reverse transcriptase, 
ciliary neuron RNA; lane 2, no RNA added; lane 3, RNA from in- 
jected ciliary neurons; lane 4, RNA from uninjected ciliary neu- 
rons; lane 5, RNA from injected TMN neurons; lane 6, RNA from 
uninjected TMN neurons; lane 7, RNA from an equivalent number 
of freshly isolated and purified El0 chicken DMTG neurons; lane 
8, RNA from 25 times more freshly isolated and purifed El4 mouse 
trigeminal neurons.  No products were detected in total RNA ex- 
tracted from injected neurons in the absence of reverse transcrip- 
tase (not shown). 
the  injected  pCMX/trkA  vector  in  both  ciliary  and  TMN 
neurons.  No  trkA  mRNA  was  detected  in  uninjected  El0 
chicken ciliary and TMN neurons maintained with CNTF or 
BDNF  (Fig.  4,  lanes  4  and  6)  nor in El0 chicken  DMTG 
neurons which respond to NGF (lane 7). This shows that the 
primers  are  selective  for  mammalian  rather  than  chicken 
trkA  under  the stringent  amplification  conditions  used. 
To compare the relative levels of trkA mRNA in pCMX/ 
trkA-injected chicken neurons with the endogenous levels of 
trkA  mRNA in neurons  that normally  depend on NGF  for 
survival,  we estimated  the relative level of trkA  mRNA in 
El4 mouse trigeminal neurons,  >90%  of which depend on 
NGF  for survival  (Buchman  and  Davies,  1993).  We  were 
able to use the same PCR primers as used for rat trkA, be- 
cause the mouse and rat trkA nucleotide sequences are iden- 
tical  in  the  primer  annealing  sites  (Martin-Zanca  et  al., 
1990;  Meakin et al.,  1992).  When RNA from pCMX/trkA- 
injected ciliary and TMN neurons was amplified alongside 
RNA from a 25-fold greater number of purified El4 trigemi- 
nal neurons, the trkA mRNA signal was greater in RNA from 
injected chicken neurons compared with RNA from mouse 
trigeminal neurons (Fig. 4; compare lanes 3 and 5 with lane 
8).  Thus,  trkA  mRNA  is expressed from injected pCMX/ 
trkA template in ciliary and TMN neurons  at a  level that is 
at least 25 times greater than in NGF-dependent trigeminal 
neurons. 
To determine if the lack of an NGF survival response from 
pCMX/trkA-injected  ciliary  neurons  was  due  to  failure  of 
trkA protein expression in these neurons,  we used immuno- 
cytochemistry  to  determine  if trkA  protein  was  translated 
from  the  rat  trkA  mRNA  template  expressed  in  pCMX/ 
trkA-injected  ciliary  neurons  (Fig.  5).  As  in  the  case  of 
pCMX/trkA-injected TMN neurons, the majority of pCMX/ 
trkA-injected ciliary neurons exhibited intense staining of the 
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tein following injection despite showing no 
NGF survival response.  Phase contrast (a, 
c, and e) and corresponding fluorescent im- 
ages (b, d,  and f) of El0 ciliary neurons. 
The neurons were either  injected with the 
pCMX/trkA expression  vector and grown 
for 24 h with 3 ng/ml CNTF (a and b) or 
remained  uninjected  and  grown  for 24  h 
with  3  ng/ml  CNTF  (c-f).  The  neurons 
were then fixed, permeabilized and stained 
for trkA protein (a-d) or exposed to Texas 
red-conjugated  second  antibody  alone  (e 
and f).  The  injected  ciliary  neurons  ex- 
hibited intense staining of the cell body (b) 
and distinct, though faint, staining of neu- 
rites  (white arrowhead), identical  to  the 
staining pattern observed for TMN neurons 
injected  with  the  pCMX/trkA  expression 
vector (see Fig. 2 b). Some uninjected neu- 
rons exhibited very faint immunoreactivity 
restricted to the cell body (d). As for TMN 
neurons  injected with the pCMX/trkA ex- 
pression vector, the staining intensity of all 
ciliary  neurons  injected  with  the pCMX/ 
trkA expression  vector was much greater 
than the low level of staining observed  in 
uninjected  neurons.  Neither  uninjected 
neurons ff) nor injected neurons (data not 
shown) were stained by secondary antibody 
alone. Bar, 100/~m. 
cell body and faint staining of neurites when grown for 24 h 
with CNTF after injection.  As for injected TMN neurons, 
we were unable to ascertain whether trkA was localized pre- 
dominantly to the plasma membrane of injected ciliary neu- 
rons. Furthermore, there may have been quantitative differ- 
ences  in  the  level  of trkA  protein  expression  in  injected 
ciliary and TMN neurons that we could not resolve by fluo- 
rescence  microscopy.  As  with  uninjected  TMN  neurons, 
uninjected ciliary neurons never displayed neurite staining 
and exhibited only very faint staining of their cell bodies with 
the antl-trkA tyrosine kinase antiserum. Neither injected nor 
uninjected ciliary neurons were stained by secondary anti- 
body alone. Although only a minority ofpCMX/trkA-injected 
ciliary neurons survived in NGF after 24 h, many of these 
(43 % +  13) showed visible neurite staining (Table I). There 
was no significant difference in the percentage of pCMX/ 
trkA-injected TMN neurons  with positive neurite  staining 
grown in the presence of BDNF compared with the percent- 
age  of pCMX/trkA-injected  ciliary  neurons  with  positive 
neurite staining grown in the presence of CNTF (72  +  11 
and 61  +  6, respectively). A small difference was observed 
in the number of neurite-stained ciliary neurons grown with 
CNTF versus NGF (61%  +  6  versus 43%  +  13,  respec- 
tively). This was probably a reflection of the reduced viabil- 
ity ofpCMX/trkA-injected ciliary neurons grown in the pres- 
ence  of  NGF  as  these  neurons  die  rapidly  under  these 
conditions. 
TMN and Ciliary Neurons Express p75 mRNA 
and Protein 
To investigate if the lack of an NGF survival response from 
pCMX/trkA-injected ciliary neurons was due to the absence 
of the low-affinity NGF receptor, p75, we used RT/PCR and 
immunocytochemistry to determine if t)75 mRNA and 1075 
protein are expressed in ciliary neurons. Using PCR primers 
based on the chicken p75 sequence (Large et al., 1989), pre- 
liminary studies generated a specific p75 amplification prod- 
uct from reverse transcribed RNA extracted from El0 ciliary 
neurons that had been purified to >95 % neurons by differen- 
tial sedimentation (Davies et al.,  1986b). Detailed quantita- 
tive comparisons in the absolute levels of 1075 mRNA be- 
tween  ciliary  and  TMN  neurons  were  then  undertaken. 
For these studies, total RNA was extracted from samples of 
purified ciliary and TMN neurons whose numbers had been 
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differences in cell number between ciliary and TMN neuron 
samples, the level of the ubiquitous, constitutively expressed 
L27 ribosomal protein mRNA was measured in these sam- 
pies by quantitative  RT/PCR amplification.  RT/PCR reac- 
tions were carried out on aliquots of  extracted RNA that were 
estimated to have the same numbers of ciliary and TMN neu- 
rons (Fig. 6).  These results clearly showed that p75 mRNA 
Figure 6.  TMN and Ciliary neurons express  p75 mRNA. Auto- 
radiographs of PCR amplification products electrophosed  on a 7 % 
nondenaturing polyacrylamide gel. Total RNA from approximately 
equal numbers of El0 TMN and ciliary neurons was reverse tran- 
scribed using  end-labeled  p75-specific primers (A) and an 88-bp 
fragment of p75 cDNA was amplified by PCR (arrow b). For quan- 
titative RT/PCR, 25 fg of a p75 cRNA control template was added 
to extracted  RNA prior to reverse transcription  and amplification. 
This  control  cRNA had  an  additional  4-bp  insert  between  the 
primer annealing  sites,  generating  a  92-bp fragment (arrow a). 
Lane 1, no reverse transcriptase (TMN neuron RNA); lane 2, no 
reverse transcriptase (ciliary neuron RNA); lane 3, no RNA added; 
lane 4, TMN neuron RNA; lane 5, ciliary neuron RNA. To verify 
that equal  amounts  of total RNA from each tissue were added to 
the  initial  reverse  transcription  reactions,  RT/PCR was  used to 
measure the amount of mRNA for the L27 ribosomal protein using 
L27-specific  end-labeled  primers  (B).  This  generated  a  127-bp 
fragment (arrow d).  These reactions  included  500 fg of an L27 
cRNA control template  that had a 4-bp insert between  the primer 
annealing  sites and yielded a  131-bp fragment (arrow c). 
Figure 7. TMN and Ciliary neurons express p75 protein.  Phase contrast (a-d) and corresponding fluorescent  images (e-h) of El0 TMN 
neurons (a, b, e, and f) and El0 ciliary neurons (c, d, g, and h) immuno-stained for p75. After the neurons were grown for 36 h in either 
BDNF (TMN neurons) or CNTF (ciliary neurons), they were fixed in 4% formaldehyde  for 30 min. They were then washed extensively 
and were incubated  with either anti-p75 antiserum (1:I000 in PBS) followed by anti-rabbit Texas red conjugate (e and g) or exposed  to 
anti-rabbit Texas red conjugate alone (f and h).  Bar,  75 #m. 
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tween the level of p75 mRNA and L27 mRNA in TMN neu- 
rons was 0.276 +  0.044 (mean +  SEM, n  =  5 separate as- 
says of different TMN neuron preparations) and the ratio 
between the level of p75 mRNA and L27 mRNA in ciliary 
neurons was 0.085  +  0.006 (mean 5: SEM, n  =  5 separate 
assays of different ciliary neuron preparations).  Thus, the 
level of p75 mRNA was approximately threefold higher in 
TMN neurons than in ciliary neurons. 
Staining of cultured TMN and ciliary neurons with a rab- 
bit polyclonal antiserum that recognizes an epitope in the ex- 
tracellular domain of the chicken p75 receptor (gift of Gisela 
Weskamp) showed that both kinds of neurons expressed this 
protein at the cell surface. The cell bodies and neurites of 
both kinds of neurons were stained by this antiserum. The 
staining of neurites was punctate in places, with the cell body 
displaying an intense peripheral ring of fluorescence charac- 
teristic of membrane staining. Neurons incubated with sec- 
ondary antibody alone were unlabeled (Fig. 7). 
Discussion 
We have shown that the survival of NGF-insensitive, BDNF- 
dependent TMN neurons can be promoted by NGF after 
trkA is synthesized in these neurons from an injected trkA 
cDNA template.  This is the first direct experimental evi- 
dence of trkA mediating an appropriate cellular response to 
NGF in an appropriate cell type, that is, NGF-promoted sur- 
vival of embryonic neurons. Previous work has shown that 
NGF causes proliferation of 3T3 fibroblasts transfected with 
trkA  cDNA  (Cordon et al.,  1991) and promotes meiotic 
maturation of oocytes injected with trkA mRNA (Nebreda et 
ai., 1991). Both of these inappropriate cellular responses to 
NGF are preceded by transphosphorylation of trkA. This in- 
dicates that activation of the tyrosine kinase domain of trkA 
in these nonneuronai cells is capable of activating second 
messenger pathways culminating in responses that are other- 
wise elicited by other factors (FGF in the case of fibroblasts 
and progesterone in the case of oocytes), trkA transfection 
also restores NGF responsiveness to a mutant PC12 pheo- 
chromocytoma cell line (Loeb et al., 1991). Our findings in- 
dicate that TMN neurons possess the intracellular compo- 
nents that are capable of transducing a trkA-mediated NGF 
signal into a survival response. Possibly these are the same 
as or similar to those activated by BDNF in TMN neurons. 
It is unclear, however,  why not quite as many trkA-injected 
TMN neurons survive with NGF as survive with BDNE 
This might be due to incomplete activation or reduced ex- 
pression of an essential effector for NGF signaling. 
Given the ability of NGF to promote a variety of cellular 
responses in diverse types of non-neuronal cells expressing 
trkA, it was surprising to find that NGF failed to promote 
the survival of embryonic ciliary neurons injected with the 
pCMX/trkA  expression vector during the stage of neuro- 
trophic factor dependence. This was not due to failure of 
trkA  mRNA  and  protein  expression  in  ciliary  neurons. 
RT/PCR  analysis  demonstrated  that  pCMX/trkA-injected 
ciliary neurons expressed as much trkA mRNA as pCMX/ 
trkA-injected TMN neurons and that the level of trkA mRNA 
in these injected neurons was >25-fold higher than the level 
of endogenous trkA mRNA in NGF-dependent sensory neu- 
rons. Furthermore, immunocytochemistry showed trkA ira- 
munoreactivity on the cell body and neurites of pCMX/trkA- 
injected ciliary neurons. The faint staining of only the cell 
body of uninjected TMN and ciliary neurons with the anti- 
trkA  antiserum was probably due to either cross-reaction 
with other tyrosine kinases or reactivity against endogenous 
trk species.  Irrespective of the reason for the low level of 
staining in uninjected neurons, injected TMN and ciliary 
neurons clearly expressed greatly elevated levels of rat trkA 
protein. There was no significant difference in the percent- 
age of pCMX/trkA-injected  ciliary neurons growing with 
CNTF  and  the  percentage  of pCMX/trkA-injected  TMN 
neurons growing with BDNF that possessed anti-trkA-stained 
neurites. This suggests that the translation of the trkA mRNA 
and the distribution of the receptor protein was similar for 
both kinds of  neuron. Neither the injection procedure nor the 
expression oftrkA protein in ciliary neurons was detrimental 
to the neurons because pCMX/trkA-injected, trkA-express- 
ing ciliary neurons survived in culture medium containing 
CNTE  We were unable to demonstrate if the rat trkA ex- 
pressed in injected TMN and ciliary neurons could be acti- 
vated by NGF because the number of injected neurons was 
too small to  permit biochemical demonstration of NGF- 
induced transphosphorylation. The ineffectiveness of NGF 
in promoting the survival of trkA-expressing  ciliary neurons 
cannot be attributed to the absence of the low-affinity NGF 
receptor, p75, because both p75 mRNA and p75 protein are 
expressed in ciliary neurons. Although quantitative RT/PCR 
showed that the level  of p75  mRNA in ciliary neurons is 
about one third that in TMN neurons, no obvious differences 
in  the  intensity of p75  immunoreactivity were  observed 
among these neurons. Thus, despite the expression of both 
trkA and p75, ciliary neurons remained refractory to NGF. 
Why do ciliary neurons that express NGF receptors fail to 
respond to NGF? Ciliary neurons may be unusual in that 
they only possess the signal transduction and intracellular 
components for surviving in response to cytokines. In con- 
trast to many kinds of embryonic neurons, ciliary neurons 
do not survive in response to any members of the NGF fam- 
ily of neurotrophic factors (Helfand et al., 1976; Lindsay et 
ai., 1985; Rohrer and Sommer, 1982; Davies et ai., 1993). 
Instead, these neurons are supported by CNTF (Barbin et 
al., 1984) which acts via a different set of cell surface recep- 
tors to those used by the NGF family of neurotrophic factors 
(Davis et ai., 1991; Ip et al.,  1992b;  Squinto et al., 1990). 
The CNTF receptor complex is thought to consist of three 
components.  A  glycosylphosphotidylinositol-liuked extra- 
cellular protein (CNTFR ot subuni0 that is homologous with 
one of the two components of the interleukin-6 (IL-6) recep- 
tor (Davis et al., 1991), a 130-kD transmembrane glycopro- 
tein (gp130) that is similar to the other component of  the IL-6 
receptor and a third component that might be related to a 
gpl30 homologue that binds leukemia inhibitory factor (Ip 
et al.,  1992b).  Binding of CNTF to responsive cells leads 
to tyrosine phosphorylation of  gpl30 and the putative gpl30- 
like component of the CNTF receptor complex, although 
these receptor components do not possess intrinsic tyrosine 
kinase activity. Phosphorylation of these receptor compo- 
nents does not occur in fibroblasts and PC12 cells in response 
to a variety of factors (including NGF, BDNF, NT-3, PDGF, 
and FGF) that utilize receptor tyrosine kinases (Ip et al., 
1992b),  suggesting  that  these  phosphorylations  may  be 
specific for the signal transduction pathways  activated by 
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steps occur subsequent to gp130 phosphorylation in ciliary 
neurons that lead to the survival of these cells. 
It is possible that the intraceUular  signal cascade leading 
to survival  in ciliary neurons has some components in com- 
mon with the signal cascade leading to survival in neurons 
that are supported by members of the NGF family of neuro- 
trophic factors.  The introduction of a constitutively active 
oncogenic form of ms p21 protein into ciliary neurons pro- 
motes their survival and neurite outgrowth in the absence of 
CNTF (Borasio et al., 1989). This suggests that downstream 
components of a signal cascade from ras p21  are present in 
ciliary neurons.  However,  function-blocking  antibodies to 
p21 c-'~ do  not  block  the  survival-promoting  effects  of 
CNTE suggesting that endogenous p21 c-'~ is not involved in 
CNTF signal transduction  leading to survival, p21 c-'~ is es- 
sential for the signal cascade in PC12 cells that is initiated 
by NGF-mediated activation  of trkA and involves MAP ki- 
rinses and the kinase raf-1 (Wood et al., 1992; Thomas et al., 
1992; Meng Sbeng and Green, 1992; Ohmich et al., 1992). 
Furthermore, recent work has shown that p21 c-'~ mediates 
the  survival  response of nodose and dorsal root ganglion 
neurons to BDNF and NGE respectively (Ng and Shooter, 
1992; Borasio et al., 1993). Our demonstration that ectopic 
expression of trkA in ciliary neurons does not confer NGF 
responsiveness suggests that activated trkA in ciliary neurons 
does not couple with guanine-nucleotide  exchange factors 
for p21 c-~.  Perhaps  ciliary neurons lack the specific SH2 
domain-containing  adapter  molecules  to  link  phosphory- 
lated trkA  receptors to the exchange factors (Egan et al., 
1993).  Ciliary neurons might therefore be a useful experi- 
mental model for elucidating the molecular mechanism of 
ras activation  by trk tyrosine receptor kinases in embryonic 
neurons. 
The recent finding  that NGF-promoted survival of sym- 
pathetic  neurons does not require functional p21 c-~ (Bora- 
sio  et  al.,  1993)  suggests  that  p21 c-ra' is  not  an  essential 
component of the signal cascade leading to survival  in all 
NGF-dependent neurons. This finding together with our cur- 
rent  study  suggests  that  downstream  of the  initial  signal 
transduction  event there are multiple intracellular signal cas- 
cades leading to survival in embryonic neurons. 
Ciliary neurons also differ from neurons that depend on 
members of the NGF family of neurotrophic factors in pos- 
sessing  a  cell  death  mechanism  that  is  insensitive  to  the 
proto-oncogene bcl-2. Over-expression ofbcl-2 prevents cell 
death in BDNF-deprived TMN neurons and NGF-deprived 
DMTG neurons, but does not rescue CNTF-deprived ciliary 
neurons (Allsopp et al.,  1993).  Thus, the difference in the 
cell death pathways in these neurons may provide an explana- 
tion for the inability of NGF to prevent cell death in ciliary 
neurons expressing trkA. 
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